Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C

Clinical trial NCT00265642 · COMPLETED

Trial details

NCT number: NCT00265642
Sponsor: ANRS, Emerging Infectious Diseases
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2006-10-01
Primary completion: 2013-04-01
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.